These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 4971465

  • 1. A double-blind study of heteronium bromide and amobarbital in the management of gastrointestinal conditions associated with anxiety.
    Kasich AM.
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):508-13. PubMed ID: 4971465
    [No Abstract] [Full Text] [Related]

  • 2. Response to trifluoperazine-amobarbital in outpatients with anxiety. (A double-blind, placebo-controlled study).
    Guthrie MB, Free SM.
    Dis Nerv Syst; 1969 Mar; 30(3):195-200. PubMed ID: 4886703
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of isopropamide on duodenal ulcer pain].
    Kadish U.
    Harefuah; 1972 Jul 02; 83(1):24-5. PubMed ID: 4404448
    [No Abstract] [Full Text] [Related]

  • 4. [Action of the bromazepam-propantheline combination in patients with organic and functional gastrointestinal disorders].
    Laghi-Pasini F.
    Clin Ter; 1977 Nov 15; 83(3):301-11. PubMed ID: 23917
    [No Abstract] [Full Text] [Related]

  • 5. [The association of lexotan + propantheline in the treatment of functional gastrointestinal disorders. Controlled clinical study].
    Riva D, Manieri L, Mariano P.
    Arch Sci Med (Torino); 1980 Nov 15; 137(3):461-6. PubMed ID: 6112973
    [No Abstract] [Full Text] [Related]

  • 6. Antianxiety drugs in organic and functional syndromes.
    Med Lett Drugs Ther; 1972 Dec 08; 14(25):93-4. PubMed ID: 4648572
    [No Abstract] [Full Text] [Related]

  • 7. A trial of amylopectin sulfate (SN-263) and propantheline bromide in the long term treatment of chronic duodenal ulcer.
    Cocking JB.
    Gastroenterology; 1972 Jan 08; 62(1):6-10. PubMed ID: 4551010
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Progress in organic or functional gastroenterologic therapeutics].
    Geoffroy H, Coudoux P, Maffioli C, Chardon P, Behar C.
    Maroc Med; 1970 Apr 08; 50(534):249-58. PubMed ID: 5491711
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical experience with FK-880 (Sulpiride)].
    Mori K, Yoshikawa K, Takahashi S.
    Naika Hokan; 1969 Oct 08; 16(10):411-5. PubMed ID: 5391802
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Global ratings compared to rating scales in evaluating trifluoperazine-amobarbital in anxious psychoneurotic outpatients.
    Bercel NA.
    Behav Neuropsychiatry; 1971 Oct 08; 2(11):15-9. PubMed ID: 4935767
    [No Abstract] [Full Text] [Related]

  • 18. Reduction of anxiety in the coronary-care unit. A controlled double-blind comparison of chlordiazepoxide and amobarbital.
    Hackett TP, Cassem NH.
    Curr Ther Res Clin Exp; 1972 Oct 08; 14(10):649-56. PubMed ID: 4628807
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.